The content on this site is intended for healthcare professionals only
Dr Cohen speaks with ecancertv at SABCS 2016 about the lessons learned from sequencing of the whole exome and transcriptome of metastatic breast cancer.
The insight in tumour evolution from primary lesions to metastatic cases highlights potential targets for personalised therapy, and forms a better understanding of molecular and metabolic pathways most highly regulated in cancer cells.
Dr Cohen presented these results at a press conference session, with video available here.
SABCS 2025: Latest developments in multigene testing in early breast cancer
ESMO 2024: Optimising the personalisation of prostate cancer treatment
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
Lung cancer screening and treatment in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
